With respect to combination therapy, in breast cancer, it has been demonstrated that activation of the FOXM1–CDK1 positive feedback loop induces replication stress, and that targeting the MMB–FOXM1 complex (e.g., LIN54) contributes to enhancing the efficacy of CHK1 inhibitors [35]. Here, FOXM1 is linked to breast carcinoma.